LXRP is another winner in progress (important update inside)
Published: Wed, 04/08/15
|
Morning all,
LXRP is trading higher today, up as much as 10% on the day so far. It was a relatively low risk, high reward play with an easy opportunity to enter and exit from my alert yesterday. We were hoping for more than 10% gains - looking for the major breakout through $0.10-0.11 - which I am hopeful we will still get, so definitely keep your eye on this one For those who are searching for bigger, faster gains, fear not. I am working on another play that has a ton of potential. Keep an eye out for my next email this evening. ShiznitStocks ---------------------------------------------------------------
Morning, The company just released this news... Lexaria's ViPova(TM) Tea Available Soon at Amazon.comKELOWNA, BC / ACCESSWIRE / April 8, 2015 / Lexaria, Corp. (LXRP) (CSE:LXX) (the "Company") is very pleased to announce that ViPova(TM) tea will soon be available for sale at Amazon.com and other online retailers."We expect to have ViPova tea available for sale at the world's largest online superstore," said Lexaria CEO Chris Bunka. "We know we need to make our products more widely available and we couldn't be more proud than to start at the top, with the world's best online retailer." Small businesses like ViPova, world-class retail brands, and individual sellers increase their sales and reach new customers by leveraging the power of the Amazon.com e-commerce platform. Amazon.com strives to be Earth's most customer-centric company and serves consumers through a focus on vast selection, price, and convenience. At peak times, Amazon USA sells as many as 426 items per second, or 36.8 million items in a single day. Some reports have indicated that 80-90 million Americans shop at Amazon.com every month. During 2014, Amazon.com reported full year revenue of approx. $88.9 Billion. Although not available at Amazon today, Lexaria believes it is important to provide disclosure regarding this important pending development as it would mark a potentially significant new sales channel, and availability at Amazon.com should be imminent. Lexaria continues to open sales channels for its ViPova (TM) brand, making progress consistently as to the number of online locations where consumers can access our premium products. These efforts are ongoing and beginning to be productive. As well, Lexaria has awarded an initial 6-month Search Engine Optimization (SEO) contract designed to increase the visibility of its online brands and support its online retailers and sellers. This SEO contract has already commenced and is expected to provide steadily improved visibility in the months to come, and will be part of our growing efforts to build brand recognition and interest in our products. Vipova(TM) encourages other retailers, either online or brick-and-mortar, that wish to carry our ground-breaking products to contact us by email at customerservice@vipova.com for distribution information. Read this press release in full at http://finance.yahoo.com/news/lexarias-vipova-tm-tea-available-120100935.html All the best today. ShiznitStocks ------------------------------------------------------------------------------- Hello fellow investors / traders, We've had a great ride these past couple weeks, and as promised, here's another potential winner.
I love going back to plays that we've had success with in the past, and Lexaria Corp (LXRP) looks to be setting up nicely to once again provide us with more gains. The first time we profiled LXRP it ran some 700% (from just below current levels all the way up to around $0.70) . The second time was a big 85% winner.
We think the chart is setup perfectly for another technical breakout.
As you can see LXRP has been trading in a tight coiled range with strong support.
LXRP is flagging and begging for a catalyst to help propel a breakout through multi-month resistance of $0.10 - 0.12.
An entry at these levels could be the perfect risk v reward play to take advantage of a possible breakout - and we think it could potentially run back to its former resting spot of around $020 - 0.30.
Especially with major news we are expecting from the company over the next couple of days. LXRP has a very small market cap of just under $3 million which is tiny relative to its peers and an even smaller float.
LXRP also boasts a strong fundamental story, here are some of the highlights...
Lexaria's New President from BioPharmaceutical Industry KELOWNA, BC / ACCESSWIRE / March 26, 2015 / Lexaria Corp. (LXRP) (CNSX:LXX) (the "Company") is pleased to announce an important addition to the Lexaria management team. John Docherty, M.Sc. is the new President of Lexaria Corp, replacing Chris Bunka who will continue at his existing positions of CEO and Chairman. Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX:HBP), where he led the company's pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. "It is with tremendous pleasure that I join Lexaria as President," said Mr. Docherty. "Lexaria's patent-pending lipid infusion technology is a significant innovation for the delivery of cannabinoid compounds from natural products, as it has already demonstrated through the launch of its ViPova(TM)-branded CBD tea. I look forward to working with the Lexaria team to grow the Company's technology and product offerings and build upon this success, in order to add value for Lexaria's customer and shareholder base alike." Mr. Docherty is a senior operations and management executive with a wealth of experience in the pharmaceutical and biopharmaceutical sectors. He has worked with large multinational companies and emerging, private and publicly held, Canadian start-ups; and he also brings specialized knowhow in the field of naturally-derived products and technologies specifically. "Mr. Docherty's expertise will be instrumental as we execute and expand upon our business plan to develop and commercialize healthy cannabinoid products to our large and growing marketplace," said outgoing President Chris Bunka. "Lexaria could not have found a better-equipped person to accelerate our transformation into a food-sciences company focused on unique methods of delivering compounds like cannabidiol, through popular food categories." Mr. Docherty has over twenty years' experience in the pharmaceutical and biopharmaceutical industries. At Helix, Mr. Docherty was also instrumental in the areas of investor/stakeholder relations, capital raising, capital markets development, strategic partnering, regulatory authority interactions and media relations, and he also served as a management member of its board of directors. Prior to this, Mr. Docherty was President and a board member of PharmaDerm Laboratories Ltd., a Canadian drug delivery company that developed unique microencapsulation formulation technologies for use with a range of active compounds. Mr. Docherty has also held positions with companies such as Astra Pharma Inc., Nu-Pharm Inc. and PriceWaterhouseCoopers' former global pharmaceutical industry consulting practice. He is a named inventor on issued and pending patents and he has a M.Sc. in pharmacology and a B.Sc. in Toxicology from the University of Toronto. KELOWNA, BC / ACCESSWIRE / March 24, 2015 / Lexaria Corp. (LXRP) (CNSX:LXX) (the "Company") announces an immediate reduction in price for a 25 -50 serving tin of ViPovaTM CBD-infused tea from US$129 to US$99. Efficiencies in the production process are allowing us to achieve lower costs, and those savings are being passed on to consumers. The lipid-infusion process is a patent-pending method used to bind the cannabidiol (CBD) with lipids for a more comforting and efficient experience. Most competitors simply mix raw CBD contained in hemp oil into their edible products, but some studies have indicated that bioabsorption of CBD in this way is very poor. According to a story published February 27 by MainStreet, George Anastassov said, "The compounds get destroyed by acid in the gastrointestinal tract, so there's not much left of the benefits of CBD's to be delivered to the blood stream. It's not only about a product containing CBD's but how much your body absorbs." Working on behalf of Vipova's customers, Vipova has during recent months made substantial engineering advances which have increased the efficiency of applying ViPova's patent-pending infusion process to its fine, Black Tea. Our customers will enjoy the same delicious, high quality CBD-infused tea from the famed Yunnan Province as they contemplate their new cost savings. The www.vipova.com website has already been changed to reflect the new pricing, and the coupon good for 30% off your second order remains in effect. LXRP Updates Shareholders on its Operations KELOWNA, BC / ACCESSWIRE / February 4, 2015 / Lexaria, Corp. (LXRP) (CSE:LXX) (the "Company") provides the following three operational updates. CREDIT CARDS Lexaria is pleased to announce it is now accepting Mastercard and Visa credit card payments at its www.vipova.com e-commerce site for sales of its patent-pending CBD-infused black tea across America. Previously, customers could only transact with the ViPova website with checks and money orders, and while these payment options remain for those who prefer them, Vipova's ability to accept major credit cards will shorten delivery times and provide the ease of ordering that customers expect. Given the increase in web traffic Vipova.com has experienced, Lexaria believes the ability to use credit cards should lead to an increase in sales volumes. Customers across the US can also call 1-888-976-8482 from 9AM to 7PM EST Mon-Fri to place their orders. FOCUS GROUPS Lexaria has begun holding focus group sessions to introduce and evaluate its CBD-infused black tea. Our first focus group was held January 29 when 14 people were introduced to ViPova Tea. The session provided a chance for potential consumers to learn about the tea and the properties of cannabidiol infusion, and proved immensely valuable to the Company to learn about consumer preferences, needs, likes and dislikes. Lexaria is very pleased at the enthusiastic response and comments received. Participants had the opportunity to meet senior representatives of ViPova, and provide detailed commentary that the Company will use to fine-tune its products and marketing as 2015 unfolds. The next focus group will be held during the next several days and the Company expects to continue to hold similar focus group meetings in the weeks and months to come. STRATEGIC ADVISOR Lexaria has engaged Sequoia Partners Inc for strategic fiscal advisement and for the development of various strategies to assist the Company to realize its project objectives. Lexaria will be working closely with the Managing Partners of Sequoia to pursue its interests. The Managing Partners have extensive and long lasting relationships in the finance, health care and pharmaceutical industries that are expected to be beneficial to the Company. Sequoia has been granted 250,000 stock options and will receive a monthly fee of CDN$5,000 for the next six months.
LXRP Making Tremendous Progress on Numerous Fronts LXRP confirmed that it has submitted an application to become a Licensed Producer under Canada's MMPR program in July 2014 and it's now in the preliminary screening process. Operations manager for Ontario, Mr. Donald Shaxon, is diligently working to progress the project through regulatory approval, while the joint venture has also requested a Ready-to-Build Letter from Health Canada.
The Burlington Joint Venture has applied to produce up to 10,000 kilograms of medical marijuana per year under Canada's MMPR program. Its partner, Enertopia Corp. (ENRT) has a 51% interest in the project, while Lexaria has a 49% interest in the project. The two have also been actively involved in the local community and working with law enforcement to improve security.
The company also confirmed the launch of a National Medical Marijuana Awareness and Outreach Strategy in conjunction with Maureen McGrath, RN, in order to educate physicians and the public about the benefits of medical marijuana. Ms. McGrath is well known for hosting the popular CKNW Sunday Night Spotlight Show - a weekly call-in radio program - as well as a number of other radio shows and magazines.
As a part of the plan, Ms. McGrath will be educating physicians, pharmacists, and other healthcare practitioners, as well as the public, on the benefits and cautions related to the responsible use of medical marijuana for patients in need. The company intends for her to reach out via town hall style meetings as well as through media outlets to liaise with those persons with interest in the field.
Lexaria's First Marijuana Production Facility
"Lexaria Corp. (LXRP) announces it has entered agreements for its first co-owned and co-managed MJ production facility in Canada. The facility is comprised initially of roughly 30,000 square feet of space, with a right of first refusal having been acquired for another 45,000 square feet to accommodate future growth. Planned production areas have 22 foot ceilings which will allow for the possibility of a 2nd mezzanine level in many areas, allowing for additional future expansion. Lexaria will own 49% interest in the production facility by paying 55% of all initial and ongoing expenses related to the project. Lexaria's Joint Venture partner, Enertopia Corp, will own a 51% interest in the production facility and pay 45% of costs. Lexaria will also issue a one-time payment of 500,000 restricted common shares to Enertopia. There are no overriding interests payable to any entity. An initial 5-year lease has been entered, with options to renew the lease for another 15 years."
As you can see, LXRP appear to be doing a lot of things right. And we think investors will sit up and take notice here, especially with the interest coming back into marijuana stocks.
The question is, do you want to get in to LXRP before the crowd, ride the breakout and maximize the gains to be made?
If so, make sure you are ready for trading tomorrow at 9:30am EST sharp.
LXRP has a low float, and a history of making big runs, so you need to be ready at the opening bell or you could miss out.
Disclaimer Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. For full disclaimer click here. |
